[CAS NO. 5536-17-4]  Vidarabine

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [5536-17-4]

Catelog
HY-B0277
Brand
MCE
CAS
5536-17-4

DESCRIPTION [5536-17-4]

Overview

MDLMFCD00065471
Molecular Weight267.24
Molecular FormulaC10H13N5O4
SMILESNC1=C(N=CN2[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O3)C2=NC=N1

For research use only. We do not sell to patients.


Summary

Vidarabine (Ara-A) an antiviral agent which is active against herpes simplex and varicella zoster viruses [1] [2] . Vidarabine has IC 50 s of 9.3 μg/ml for HSV-1 and 11.3 μg/ml for HSV-2 [2] . Vidarabine also has anti- orthopoxvirus activity [3] .


IC50 & Target

HSV-2

11.3 μg/mL (IC 50 )

HSV-1

9.3 μg/mL (IC 50 )


In Vitro

Vidarabine (Ara-A) is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia VIRUS and varicella zoster virus [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT00000985 National Institute of Allergy and Infectious Diseases (NIAID)
Herpes Simplex|HIV Infections
Phase 3

Appearance

Solid


Source

Streptomyces


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL ( 187.10 mM ; Need ultrasonic)

H 2 O : 0.67 mg/mL ( 2.51 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.7420 mL 18.7098 mL 37.4195 mL
5 mM 0.7484 mL 3.7420 mL 7.4839 mL
10 mM 0.3742 mL 1.8710 mL 3.7420 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.5 mg/mL (9.35 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (9.35 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (9.35 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-
Adenine, 9-β-D-arabinofuranosyl-
9-β-D-Arabinofuranosyl-9H-purin-6-amine
Arabinosyladenine
9-β-D-Arabinofuranosyladenine
Adenine arabinoside
β-D-Arabinosyladenine
9-Arabinosyladenine
Vidarabine
Ara-A
CI-673
Vidarabin
Adenine β-D-arabinofuranoside
NSC 404241
Araadenosine
Spongoadenosine
9-β-D-Arabinoadenosine
6-Amino-9-β-D-arabinofuranosylpurine
9-β-D-Arabinosyladenine
Adenine 9-β-D-arabinofuranoside
β-D-Arabinofuranosyladenine
β-Ara-A
Vira-A
Arasena-A
Vidarabine anhydrous
NSC 247519
NQZ-071